The head of the US Department of Health and Human Services, Robert F. Kennedy Jr., recently announced significant funding cuts for mRNA vaccine development,...
Federal officials announced on July 15, 2023, their intention to classify 7-hydroxymitragynine, commonly known as 7-OH, as a Schedule I controlled substance. This decision,...